theranos · elizabeth holmes
entry · 2003–2018 · status: archived · 11.25 years for holmes · 13 years for balwani
summary
Theranos was a biotech company founded by Stanford dropout Elizabeth Holmes in 2003. It claimed to have developed a proprietary blood-testing device — the "Edison" — that could perform 240+ medical tests from a single drop of blood drawn from a finger-prick. The company reached a peak paper valuation of $9 billion in 2014, raised approximately $700 million from investors including Rupert Murdoch, Larry Ellison, the Walton family, and Betsy DeVos's family, and partnered with Walgreens to deploy the technology in retail wellness centers serving real patients. The technology did not work. Holmes was convicted on four counts of fraud in January 2022 and sentenced to 11 years 3 months in federal prison.
the receipts
- The board. A roster of former U.S. Secretaries of State and Defense — George Shultz, Henry Kissinger, James Mattis, William Perry, Sam Nunn — providing institutional cover. None had medical or biotech expertise.
- The deception. The Edison device's test results were unreliable; Theranos secretly ran most patient samples on standard commercial laboratory machines (Siemens) it had purchased and modified. Holmes told investors, partners, and patients the proprietary technology was performing the tests. It was not.
- The patients. Walgreens deployed Theranos technology in dozens of retail locations starting 2013. Real patients received unreliable test results — including false positives for HIV and miscarriages — that led to medical decisions based on fabricated data.
- The whistleblowers. Tyler Shultz (grandson of board member George Shultz, then 23) and Erika Cheung internally raised concerns from 2014. They were threatened with lawsuits and tailed by private investigators retained by Theranos. They went to journalist John Carreyrou anyway.
- The exposure. Carreyrou's Wall Street Journal investigation, October 15, 2015, broke the story. The company collapsed over the next three years.
- Convictions. SEC charges 2018. Federal indictment June 2018. Holmes convicted on four counts (defrauding investors); acquitted on patient-fraud counts; sentenced May 2022 to 11 years 3 months. President / COO Sunny Balwani convicted on all 12 counts December 2022; sentenced to ~13 years.
why this matters to PRIOR
Theranos is the modern case study in institutional cover producing investment licit. Holmes was 19 when she founded the company. She had no medical training. The product never worked. What made the fraud possible was not the deception itself but the institutional roster — Henry Kissinger, James Mattis, Walgreens — that signaled the company was real. By the time the journalists arrived, real patients had received fabricated test results in clinical settings. The pattern recurs: the institutional brand carries the fraud. Investors do not perform technical due diligence on companies that have James Mattis on the board. The board members were paid in equity that became worthless. The patients had been paid in test results that were already worthless.
"a $9 billion valuation built on a device that did not work. the journalists were paid in book deals. the patients had been paid in fake test results."